These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11249678)

  • 21. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
    Hill AV; Reece W; Gothard P; Moorthy V; Roberts M; Flanagan K; Plebanski M; Hannan C; Hu JT; Anderson R; Degano P; Schneider J; Prieur E; Sheu E; Gilbert SC
    Dev Biol (Basel); 2000; 104():171-9. PubMed ID: 11713817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine adjuvants: is the pipeline clogged?
    Leitner WW
    Immunotherapy; 2012 Jun; 4(6):565-7. PubMed ID: 22788122
    [No Abstract]   [Full Text] [Related]  

  • 24. Incorporation of immunomodulators into plasmid DNA vaccines.
    Klavinskis LS; Hobson P; Woods A
    Methods Mol Med; 2003; 87():195-210. PubMed ID: 12958457
    [No Abstract]   [Full Text] [Related]  

  • 25. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.
    Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G
    Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
    Fujihashi K; Kiyono H
    Trends Immunol; 2009 Jul; 30(7):334-43. PubMed ID: 19540811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction and detection of T-cell responses.
    Mills KH
    Methods Mol Med; 2003; 87():255-78. PubMed ID: 12958461
    [No Abstract]   [Full Text] [Related]  

  • 28. [The role of Lactobacillus acidophilus in the prevention and adjuvant therapy of certain infectious diseases].
    Halmy C; Halmy L
    Orv Hetil; 1998 Sep; 139(39):2313-8. PubMed ID: 9789985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
    Snyder LA; Goletz TJ; Gunn GR; Shi FF; Harris MC; Cochlin K; McCauley C; McCarthy SG; Branigan PJ; Knight DM
    Vaccine; 2006 Apr; 24(16):3340-52. PubMed ID: 16472547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passive antibody therapy for infectious diseases.
    Casadevall A; Dadachova E; Pirofski LA
    Nat Rev Microbiol; 2004 Sep; 2(9):695-703. PubMed ID: 15372080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.
    Datta SK; Cho HJ; Takabayashi K; Horner AA; Raz E
    Immunol Rev; 2004 Jun; 199():217-26. PubMed ID: 15233737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleic acid vaccination strategies against infectious diseases.
    Marć MA; Domínguez-Álvarez E; Gamazo C
    Expert Opin Drug Deliv; 2015; 12(12):1851-65. PubMed ID: 26365499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses.
    Pearse MJ; Drane D
    Vaccine; 2004 Jun; 22(19):2391-5. PubMed ID: 15193400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques.
    Amara RR; Sharma S; Patel M; Smith JM; Chennareddi L; Herndon JG; Robinson HL
    Virology; 2005 Mar; 334(1):124-33. PubMed ID: 15749128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.
    Huang Y; Chen A; Li X; Chen Z; Zhang W; Song Y; Gurner D; Gardiner D; Basu S; Ho DD; Tsuji M
    Vaccine; 2008 Mar; 26(15):1807-16. PubMed ID: 18329757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for designing and optimizing new generation vaccines.
    Berzofsky JA; Ahlers JD; Belyakov IM
    Nat Rev Immunol; 2001 Dec; 1(3):209-19. PubMed ID: 11905830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiological aspects of the resistance of infectious agents].
    Perepelkin VS; Spirande VV
    Voen Med Zh; 1978 Jul; (7):46-50. PubMed ID: 354194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.